Matches 1 - 24 out of 24


Match Document Document Title
US20140088339 Method and System for Treatment of Cardiovascular Disorders  
Methods for treating a cardiovascular disorder comprising concomitant administration of one or more extracellular matrix (ECM) based compositions directly to damaged or diseased cardiovascular...
US20140335046 Compositions, Methods and Systems for Regenerative Cosmetics  
A method of inducing or promoting hair growth on the scalp of a subject, comprising the steps of (i) providing an ECM composition including at least one ECM material, (ii) administering inciting...
US20150110754 High Resolution Allele Identification  
Provided herein are methods for accurately determining the alleles present at a locus that is broadly applicable to any locus, including highly polymorphic loci such as HLA loci, BGA loci and HV...
US20150182560 TISSUE ENGINEERING OF LUNG  
The present invention relates to compositions comprising a decellularized tissue. The present invention also provides an engineered three dimensional lung tissue exhibiting characteristics of a...
US20120064050 Tissue Engineering of Lung  
The present invention relates to compositions comprising a decellularized tissue. The present invention also provides an engineered three dimensional lung tissue exhibiting characteristics of a...
US20120226218 EXTRACELLULAR MATRIX MATERIAL CREATED USING NON-THERMAL IRREVERSIBLE ELECTROPORATION  
Extracellular matrix material is disclosed which is created by subjecting a target area to non-thermal irreversible electroporation (NTIRE) with a pulsed electrical field to kill cells in the...
US20140248371 SPALAX FIBROBLAST-DERIVED ANTI-CANCER AGENTS  
A conditioned cell culture medium of cells derived from Spalax or naked mole rat (Heterocephalus glaber) and methods for preparing it are provided. Pharmaceutical compositions comprising the...
US20080305180 Method of administration of a pulmonary surfactant  
The present invention concerns a method for treating a respiratory distress in a infant in need of such treatment, the method comprising intratracheal administration of a pulmonary surfactant by a...
US20120225056 METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS  
The present disclosure relates to, inter alia, compositions containing an inhibitor of human complement and use of the compositions in methods for treating or preventing complement-associated...
US20110083201 COMPOSITIONS FOR AND METHODS OF GRAZYME B INHIBITION  
The present invention is related to the discovery that serpina3n, a secreted protein, binds to and inhibits granzyme B activity. The invention thus provides cells that include a polynucleotide...
US20130236453 Methods and Compositions for Modulating Acute Graft-versus-Host Disease using miR-155 Specific Inhibitors  
Methods and compositions for treating or preventing acute graft-versus-host disease (aGVHD) in a subject using miR-155 specific inhibitors are described.
US20080260854 Sirna Molecules for the Treatment of Blood Vessels  
The present invention relates to a nucleic acid molecule, a genetic construct, siRNA molecules and a composition which comprises the nucleic acid molecule and/or the genetic construct and/or the...
US20170072100 Method and Apparatus for Decellularization of Tissue  
Methods of decellularization of tissue, such as mammalian tissue, are provided, along with methods of making an extracellular matrix (ECM) preparation. Systems and apparatus useful in performing...
US20160184479 TISSUE-BASED COMPOSITIONS AND METHODS OF USE THEREOF  
Compositions comprising extracellular matrix (ECM) materials and methods of use thereof are disclosed. The compositions may comprise two or more ECM materials derived from different types of...
US20160051731 HYBRID GEL COMPRISING PARTICULATE DECELLULARIZED TISSUE  
A hybrid gel comprising a particulate decellularized tissue (obtained by pulverizing animal-derived biological tissues that are decellularized (decellularized biological tissues)), fibrinogen and...
US20160022868 Tissue Prostheses for Repairing, Reconstructing and Replacing Damaged or Diseased Biological Structures and Associated Tissue  
Non-antigenic, resilient, bioremodelable, biocompatible tissue prostheses that can be engineered into a variety of shapes and used to repair, augment, reconstruct or replace damaged or diseased...
US20150359939 Extracellular Matrix Encasement Structures and Methods  
A bioremodelable encasement structure comprising a pouch formed from at least one sheet of bioremodelable material, the pouch including an internal region that is configured to receive a device...
US20150359938 Extracellular Matrix Encasement Structures and Methods  
A bioremodelable encasement structure comprising a pouch formed from at least one sheet of bioremodelable material, the pouch including an internal region that is configured to receive a device...
US20150359937 Extracellular Matrix Encasement Structures and Methods  
A bioremodelable encasement structure comprising a pouch formed from at least one sheet of bioremodelable material, the pouch including an internal region that is configured to receive a device...
US20150359936 Extracellular Matrix Encasement Structures and Methods  
A bioremodelable encasement structure comprising a pouch formed from at least one sheet of bioremodelable material, the pouch including an internal region that is configured to receive a device...
US20150359935 Extracellular Matrix Encasement Structures and Methods  
A bioremodelable encasement structure comprising a pouch formed from at least one sheet of bioremodelable material, the pouch including an internal region that is configured to receive a device...
US20150352254 Extracellular Matrix Prostheses for Treating Damaged Biological Tissue  
Particulate structures comprising a particulate extracellular matrix (ECM) component encased in a biomaterial composition, which, when administered to damaged cardiovascular tissue, induce...
US20150297639 TREATING CANCER  
The specification provides compositions and methods for treating cancer with non cancerous cell extracellular vesicles. Extracellular vesicles act as a surrogate microenvironment to reverse the...
US20150284689 STRATEGY FOR ENGINEERING VARIOUS 3D TISSUES, ORGANOIDS AND VASCULATURE  
Provided are methods and compositions for constructing stable mammalian epithelial and/or endothelial tissues and organs. Disclosed are methods of using active epithelial and/or endothelial growth...

Matches 1 - 24 out of 24